Dublin, July 01, 2026 (GLOBE NEWSWIRE) — The “Nanorobotics Market by Type, Deployment, Technology-Global Forecast to 2032” has been added to ResearchAndMarkets.com’s offering.
The global nanorobotics market is projected to expand significantly, rising from USD 2.27 billion in 2025 to USD 4.52 billion by 2032, reflecting a CAGR of 10.6% from 2026 to 2032. This growth is largely driven by increasing government and private investments in nanotechnology R&D, alongside heightened collaboration between research institutes and industry leaders which are fast-tracking technological advancements. Moreover, the growing application of nanorobotics in materials science, semiconductor research, and nanoscale manufacturing boosts market expansion.
By type, the nano-manipulator segment holds the largest share during the forecast period
The nano-manipulators segment is anticipated to maintain the largest market share during this period. Nano-manipulators are pivotal tools in the precise positioning, probing, and manipulation at the nanoscale vital for materials science, semiconductor research, and life sciences studies. Their strong market presence is sustained by their proven performance, higher technological maturity, and seamless integration into existing research workflows. Consistent demand for high-precision nanoscale analysis across academic and industrial settings continues to drive their widespread adoption, reinforcing nano-manipulators’ dominant position in the global nanorobotics market.
Pharma & biotech companies segment expected to register the highest CAGR during the forecast period
The pharma & biotech companies segment is forecasted to grow at the highest CAGR during the forecast period. This surge is driven by the increasing need for advanced drug development and precision treatment technologies. These companies are increasingly deploying nanorobotics systems for targeted drug delivery, nanosurgery, tissue repair, and in vivo research to enhance therapeutic efficacy and mitigate side effects. Rising investments in biologics, regenerative medicine, and personalized therapies further contribute to the demand for precise and controllable nanoscale solutions.
China to be the largest market for nanorobotics in the Asia Pacific
China is expected to dominate the nanorobotics market in the Asia Pacific region during the forecast period. The country possesses a robust ecosystem of universities, national laboratories, and research institutes engaged in nanorobotics development supporting both in vitro and in vivo applications. Moreover, China’s burgeoning pharmaceutical and biotechnology sectors are expediting the adoption of nanorobotics for drug delivery, diagnostics, and next-gen medical research. Strong policy support, increasing R&D investments, and collaboration between academia and industry bolster China’s lead, making it the key contributor to market growth in the region.
Research Coverage
This report categorizes the nanorobotics market by type (nano-manipulators and nanorobotics systems), deployment, technology, application (drug delivery, diagnostics, nano-surgery & tissue repair), end user, and region. The report identifies major drivers, restraints, challenges, and opportunities and forecasts the market growth through 2032. It includes leadership mapping and comprehensive analysis of all companies in the nanorobotics market ecosystem.
Top players within the nanorobotics market include JEOL LTD. (Japan), Thermo Fisher Scientific Inc. (US), Bruker (Germany), Hitachi High-Tech Corporation (Japan), ZEISS Group (Germany), Oxford Instruments (UK), EV Group (Austria), and Park Systems (South Korea). Detailed competitive analysis of these key players is provided, including company profiles, recent developments, and strategic market initiatives.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 215 |
| Forecast Period | 2026-2032 |
| Estimated Market Value (USD) in 2026 | $2.27 Billion |
| Forecasted Market Value (USD) by 2032 | $4.52 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
Market Dynamics
- Drivers
- Strong Healthcare Demand for Better Clinical Translation and Investment
- Increasing Government Support and Level of Investment in Nanorobotics
- Rising Focus on Nanotechnology and Regenerative Medicine
- Challenges
- Commercialization of Nanorobotics Systems
- Opportunities
- Growing Demand of Oncology and Precision Therapeutics
- Increasing Use of AI-Guided Imaging Systems, Enhancing Nanorobotics Navigation and Monitoring
Company Profiles
- Bruker
- Jeol Ltd.
- Thermo Fisher Scientific Inc.
- Hitachi High-Tech Corporation
- Zeiss Group
- Park Systems
- Oxford Instruments
- Ev Group (Evg)
- Theranautilus
- Ciqtek Co., Ltd.
- Imina Technologies SA
- Nanobiotix
- Nanolive
- Toronto Nano Instrumentation Inc.
- Klocke Nanotechnik GmbH
- Kleindiek Nanotechnik GmbH
- Smaract GmbH
- Nanosurf
- Ginkgo Bioworks
- Stereotaxis, Inc.
- Bionaut Labs, Inc.
- Novascan Technologies, Inc.
- Dna Nanobots, Inc.
- Angstrom Advanced Inc.
- Nenovision S.R.O.
For more information about this report visit https://www.researchandmarkets.com/r/pr4ruh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
